Literature DB >> 28240836

Liver transplantation for severe alcoholic hepatitis-The CON view.

James Y Y Fung1,2.   

Abstract

In patients with severe alcoholic hepatitis (AH) who have failed medical therapy, liver transplantation (LT) remains a controversial therapeutic option. This is exemplified by the fact that most of these patients will not have had a period of abstinence prior to consideration for transplantation. Both abstinence before transplantation and the duration of abstinence are important predictors of post-transplant relapse. Furthermore, relapse after transplantation has been associated with accelerated graft injury and increase mortality. Recent pilot studies have demonstrated a benefit in short-term survival with early transplantation in highly selected small number of patients compared to matched controls. The results of these studies raises the possibility of extending graft allocation to these subjects. Despite stringent assessment and a multi-tiered approach to selecting out patients for transplantation, the relapse rate was not insignificant at 12%. As the long-term outcome remains unclear, further relapses with time can still occur. These studies also highlight the fact that the overwhelming majority of subjects with severe AH who are non-responsive to medical therapy are not suitable for LT. Indeed, further large-scale multicentre prospective studies with long-term follow-up are required to confirm the preliminary findings.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  alcohol hepatitis; alcoholic liver disease; liver transplantation

Mesh:

Year:  2017        PMID: 28240836     DOI: 10.1111/liv.13286

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  5 in total

1.  Model to Calculate Harms and Benefits of Early vs Delayed Liver Transplantation for Patients With Alcohol-Associated Hepatitis.

Authors:  Brian P Lee; Sumeyye Samur; Ozden O Dalgic; Emily D Bethea; Michael R Lucey; Ethan Weinberg; Christine Hsu; Mary E Rinella; Gene Y Im; Oren K Fix; George Therapondos; Hyosun Han; David W Victor; Michael D Voigt; Sheila Eswaran; Norah A Terrault; Jagpreet Chhatwal
Journal:  Gastroenterology       Date:  2019-04-15       Impact factor: 22.682

Review 2.  Proceedings from the 2018 Canadian Association for the Study of the Liver Single Topic Conference-Decompensated cirrhosis: from clinic to transplant.

Authors:  Victor Dong; Maxime Gosselin; Nishita Jagarlamudi; Beverley Kok; Mark G Swain; Jasmohan S Bajaj; Juan G Abraldes; Vladimir Marquez; R Todd Stravitz; Aldo J Montano-Loza; Manuela Merli; Phil Wong; Amanda Brisebois; Puneeta Tandon; Julia Wendon; Scott L Nyberg; François M Carrier; Michael R Lucey; Florence Wong; Jordan J Feld; Constantine J Karvellas; Christopher F Rose; Julien Bissonnette
Journal:  Can Liver J       Date:  2019-12-10

3.  National Trends and Long-term Outcomes of Liver Transplant for Alcohol-Associated Liver Disease in the United States.

Authors:  Brian P Lee; Eric Vittinghoff; Jennifer L Dodge; Giuseppe Cullaro; Norah A Terrault
Journal:  JAMA Intern Med       Date:  2019-03-01       Impact factor: 21.873

Review 4.  Emerging Noninvasive Biomarkers, and Medical Management Strategies for Alcoholic Hepatitis: Present Understanding and Scope.

Authors:  Khushboo S Gala; Vatsalya Vatsalya
Journal:  Cells       Date:  2020-02-25       Impact factor: 6.600

5.  Patients' Perspectives on Early Liver Transplantation in Alcohol-Related Liver Disease.

Authors:  Eric Wong; Paul D Mullins; Jean-Philippe Wallach; Eric M Yoshida; Sigfried R Erb; Jo-Ann Ford; Charles H Scudamore; Vladimir Marquez
Journal:  Hepatol Commun       Date:  2019-06-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.